Please login to the form below

Not currently logged in
Email:
Password:

David Theil joins Noxilizer as chief financial officer

He also takes up the role of senior vice president

US-based biotech Noxilizer has appointed David Theil as its new chief financial officer and senior vice president.

Theil has over 25 years of experience in financial, administrative and operational management, specialising in start-up and middle market life sciences companies.

Before joining the biotechnology firm, Theil held various senior management positions at IGEN International, Speciality Pharmaceuticals and Supernus Pharmaceuticals.

He has also served as manager of emerging business markets group for Deloitte & Touche where he worked with clients in biotechnology, communications, healthcare and technology companies.

Lawrence Bruder, Noxilizer's president and chief executive officer, said: “David brings experience that is critical to Noxilizer at this stage of the company.

“He has worked in growing companies and understands the opportunities and challenges.”

28th January 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics